Transplantul – o speranță la viață. Caz clinic
Închide
Articolul precedent
Articolul urmator
473 4
Ultima descărcare din IBN:
2023-12-02 12:38
SM ISO690:2012
TARAN, Natalia, HOTINEANU, Adrian, BURGOCI, Serghei, LUPAŞCO, Iulianna, PELTEC, Angela. Transplantul – o speranță la viață. Caz clinic. In: Congresul consacrat aniversării a 75-a de la fondarea Universității de Stat de Medicină şi Farmacie „Nicolae Testemiţanu”, 21-23 octombrie 2020, Chişinău. Chişinău: USMF, 2020, p. 454.
EXPORT metadate:
Google Scholar
Crossref
CERIF

DataCite
Dublin Core
Congresul consacrat aniversării a 75-a de la fondarea Universității de Stat de Medicină şi Farmacie „Nicolae Testemiţanu” 2020
Congresul "Congresul consacrat aniversării a 75-a de la fondarea Universității de Stat de Medicină şi Farmacie „Nicolae Testemiţanu”"
Chişinău, Moldova, 21-23 octombrie 2020

Transplantul – o speranță la viață. Caz clinic

Transplantation – a survival chance. Clinical case


Pag. 454-454

Taran Natalia, Hotineanu Adrian, Burgoci Serghei, Lupaşco Iulianna, Peltec Angela
 
Universitatea de Stat de Medicină şi Farmacie „Nicolae Testemiţanu“
 
Proiecte:
 
Disponibil în IBN: 31 martie 2021


Rezumat

Background. Malnutrition increases mortality on the waiting list. Hydrothorax, renal dysfunction, MELD score >17 affect prognosis. Objective of the study. The case is 56 years old patient, cirrhosis, on the waiting list since 2017. Material and Methods. Investigated according to the LT protocol: biochemical analyzes, nasopharynx cultures, uroculture, hemoculture, pleural fluid, ascites; tumor markers, viral, autoimmune. Examined vital functions. Pulmonary CT: bilateral hydrothorax (D>S). Abdominal CT: ascites, splenomegaly, v. portae thrombosis, EDS- esophageal varices dgr II-III; HBV DNA 1 552 UI / ml, HDV RNA – 2 458 570 UI / ml. Results. Confirmed HBV /VHD HC, Child Pugh C (11 p). Hypersplenism dgr. II-III., MELD Na 20.7. Esophageal varices dgr II-III. Portal gastropathy. Recurrent hydrothorax. Thrombosis v. portae. Severe malnutrition BMI <18.5 portal enteropathy. Hyponatremia. LT from brain-dead donor, age <30 years, comorbidities abs. Rehabilitation period: Na+diminished, renal dysfunction, ascites, pseudomembranous colitis Cl. Difficile. Post-LT abdominal CT: stenosis v. portae, at anastomosis level, surgically resolved. Administered etiopathogenetic, immunosuppressive treatment adapted to disease features. 12 months post LT: absence of ascites, normal biochemical parameters, except creatinine 125 umoll, BMI –Conclusion. LT is the only treatment in the terminal stage. Postoperative evolution involves: age, nutritional status, renal dysfunction, viral infection, MELD score – receiver; age, quality of liver transplant – donor.

Introducere. Malnutriția este una dintre cauzele mortalității pacienților din lista de așteptare. Hidrotoracele, disfuncția renală, scorul MELD >17 afectează prognosticul. Scopul lucrării. Se prezintă cazul pacientului cirotic, 56 de ani, pe lista de așteptare din 2017. Material și Metode. Investigat conform protocolului TH: analize biochimice, culturile nasofaringe, urocultura, hemocultura, lichidul pleural, ascitic; markerii tumorali, virali, autoimuni. Examinate funcțiile vitale. CT pulmonară: Hidrotorace bilateral (D>S). CT abdominală: ascită, splenomegalie, tromboza v. portae, EDS- varice esofagiene gr II-III; ADN VHB – 1 552 UI / ml, ARN VHD – 2 458 570 UI / ml. Rezultate. Diagnosticat CH VHB/VHD, st Child Pugh C (11 p). Hipersplenism gr. II-III., MELD Na 20.7. Varice esofagiene gr II-III. Gastropatie portală. Hidrotorace recidivant. Tromboza v. portae. Malnutriție severă IMC<18.5. Enteropatie portală. Hiponatriemie. TH donator în moarte cerebrală, <30 ani, comorbidități abs. Evoluția postoperatorie: Na+diminuat, disfuncție renală, ascită, colită pseudomembranoasă Cl. Difficile. CT abdominală post TH: stenoza v. portae, nivelul anastomozei, rezolvată chirurgical. Administrat tratament etiopatogenetic/ imunosupresiv, adaptat particularităților bolii. 12 luni post TH: absența ascitei, parametrii biochimici normali, IMC – 24.5, excepție creatinina – 125. Concluzii. TH este unicul tratament în stadiul terminal. Prognosticul și evoluția bolii implică: vârsta, statutul nutrițional, disfuncția renală, infecția virală, scorul MELD – recipient; vârsta, calitatea grefei hepatice – donator.

Cuvinte-cheie
liver cirrhosis (LC), liver transplantation (LT),

ciroza hepatica (CH), transplant hepatic (TH)

Cerif XML Export

<?xml version='1.0' encoding='utf-8'?>
<CERIF xmlns='urn:xmlns:org:eurocris:cerif-1.5-1' xsi:schemaLocation='urn:xmlns:org:eurocris:cerif-1.5-1 http://www.eurocris.org/Uploads/Web%20pages/CERIF-1.5/CERIF_1.5_1.xsd' xmlns:xsi='http://www.w3.org/2001/XMLSchema-instance' release='1.5' date='2012-10-07' sourceDatabase='Output Profile'>
<cfResPubl>
<cfResPublId>ibn-ResPubl-126264</cfResPublId>
<cfResPublDate>2020</cfResPublDate>
<cfStartPage>454</cfStartPage>
<cfISBN></cfISBN>
<cfURI>https://ibn.idsi.md/ro/vizualizare_articol/126264</cfURI>
<cfTitle cfLangCode='RO' cfTrans='o'>Transplantul &ndash; o speranță la viață. Caz clinic</cfTitle>
<cfKeyw cfLangCode='RO' cfTrans='o'>liver cirrhosis (LC); liver transplantation (LT); ciroza hepatica (CH); transplant hepatic (TH)</cfKeyw>
<cfAbstr cfLangCode='EN' cfTrans='o'><p>Background. Malnutrition increases mortality on the waiting list. Hydrothorax, renal dysfunction, MELD score &gt;17 affect prognosis. Objective of the study. The case is 56 years old patient, cirrhosis, on the waiting list since 2017. Material and Methods. Investigated according to the LT protocol: biochemical analyzes, nasopharynx cultures, uroculture, hemoculture, pleural fluid, ascites; tumor markers, viral, autoimmune. Examined vital functions. Pulmonary CT: bilateral hydrothorax (D&gt;S). Abdominal CT: ascites, splenomegaly, v. portae thrombosis, EDS- esophageal varices dgr II-III; HBV DNA 1 552 UI / ml, HDV RNA &ndash; 2 458 570 UI / ml. Results. Confirmed HBV /VHD HC, Child Pugh C (11 p). Hypersplenism dgr. II-III., MELD Na 20.7. Esophageal varices dgr II-III. Portal gastropathy. Recurrent hydrothorax. Thrombosis v. portae. Severe malnutrition BMI &lt;18.5 portal enteropathy. Hyponatremia. LT from brain-dead donor, age &lt;30 years, comorbidities abs. Rehabilitation period: Na+diminished, renal dysfunction, ascites, pseudomembranous colitis Cl. Difficile. Post-LT abdominal CT: stenosis v. portae, at anastomosis level, surgically resolved. Administered etiopathogenetic, immunosuppressive treatment adapted to disease features. 12 months post LT: absence of ascites, normal biochemical parameters, except creatinine 125 umoll, BMI &ndash;Conclusion. LT is the only treatment in the terminal stage. Postoperative evolution involves: age, nutritional status, renal dysfunction, viral infection, MELD score &ndash; receiver; age, quality of liver transplant &ndash; donor.</p></cfAbstr>
<cfAbstr cfLangCode='RO' cfTrans='o'><p>Introducere. Malnutriția este una dintre cauzele mortalității pacienților din lista de așteptare. Hidrotoracele, disfuncția renală, scorul MELD &gt;17 afectează prognosticul. Scopul lucrării. Se prezintă cazul pacientului cirotic, 56 de ani, pe lista de așteptare din 2017. Material și Metode. Investigat conform protocolului TH: analize biochimice, culturile nasofaringe, urocultura, hemocultura, lichidul pleural, ascitic; markerii tumorali, virali, autoimuni. Examinate funcțiile vitale. CT pulmonară: Hidrotorace bilateral (D&gt;S). CT abdominală: ascită, splenomegalie, tromboza v. portae, EDS- varice esofagiene gr II-III; ADN VHB &ndash; 1 552 UI / ml, ARN VHD &ndash; 2 458 570 UI / ml. Rezultate. Diagnosticat CH VHB/VHD, st Child Pugh C (11 p). Hipersplenism gr. II-III., MELD Na 20.7. Varice esofagiene gr II-III. Gastropatie portală. Hidrotorace recidivant. Tromboza v. portae. Malnutriție severă IMC&lt;18.5. Enteropatie portală. Hiponatriemie. TH donator &icirc;n moarte cerebrală, &lt;30 ani, comorbidități abs. Evoluția postoperatorie: Na+diminuat, disfuncție renală, ascită, colită pseudomembranoasă Cl. Difficile. CT abdominală post TH: stenoza v. portae, nivelul anastomozei, rezolvată chirurgical. Administrat tratament etiopatogenetic/ imunosupresiv, adaptat particularităților bolii. 12 luni post TH: absența ascitei, parametrii biochimici normali, IMC &ndash; 24.5, excepție creatinina &ndash; 125. Concluzii. TH este unicul tratament &icirc;n stadiul terminal. Prognosticul și evoluția bolii implică: v&acirc;rsta, statutul nutrițional, disfuncția renală, infecția virală, scorul MELD &ndash; recipient; v&acirc;rsta, calitatea grefei hepatice &ndash; donator.</p></cfAbstr>
<cfResPubl_Class>
<cfClassId>eda2d9e9-34c5-11e1-b86c-0800200c9a66</cfClassId>
<cfClassSchemeId>759af938-34ae-11e1-b86c-0800200c9a66</cfClassSchemeId>
<cfStartDate>2020T24:00:00</cfStartDate>
</cfResPubl_Class>
<cfResPubl_Class>
<cfClassId>e601872f-4b7e-4d88-929f-7df027b226c9</cfClassId>
<cfClassSchemeId>40e90e2f-446d-460a-98e5-5dce57550c48</cfClassSchemeId>
<cfStartDate>2020T24:00:00</cfStartDate>
</cfResPubl_Class>
<cfPers_ResPubl>
<cfPersId>ibn-person-13440</cfPersId>
<cfClassId>49815870-1cfe-11e1-8bc2-0800200c9a66</cfClassId>
<cfClassSchemeId>b7135ad0-1d00-11e1-8bc2-0800200c9a66</cfClassSchemeId>
<cfStartDate>2020T24:00:00</cfStartDate>
</cfPers_ResPubl>
<cfPers_ResPubl>
<cfPersId>ibn-person-11176</cfPersId>
<cfClassId>49815870-1cfe-11e1-8bc2-0800200c9a66</cfClassId>
<cfClassSchemeId>b7135ad0-1d00-11e1-8bc2-0800200c9a66</cfClassSchemeId>
<cfStartDate>2020T24:00:00</cfStartDate>
</cfPers_ResPubl>
<cfPers_ResPubl>
<cfPersId>ibn-person-42616</cfPersId>
<cfClassId>49815870-1cfe-11e1-8bc2-0800200c9a66</cfClassId>
<cfClassSchemeId>b7135ad0-1d00-11e1-8bc2-0800200c9a66</cfClassSchemeId>
<cfStartDate>2020T24:00:00</cfStartDate>
</cfPers_ResPubl>
<cfPers_ResPubl>
<cfPersId>ibn-person-13436</cfPersId>
<cfClassId>49815870-1cfe-11e1-8bc2-0800200c9a66</cfClassId>
<cfClassSchemeId>b7135ad0-1d00-11e1-8bc2-0800200c9a66</cfClassSchemeId>
<cfStartDate>2020T24:00:00</cfStartDate>
</cfPers_ResPubl>
<cfPers_ResPubl>
<cfPersId>ibn-person-11473</cfPersId>
<cfClassId>49815870-1cfe-11e1-8bc2-0800200c9a66</cfClassId>
<cfClassSchemeId>b7135ad0-1d00-11e1-8bc2-0800200c9a66</cfClassSchemeId>
<cfStartDate>2020T24:00:00</cfStartDate>
</cfPers_ResPubl>
</cfResPubl>
<cfPers>
<cfPersId>ibn-Pers-13440</cfPersId>
<cfPersName_Pers>
<cfPersNameId>ibn-PersName-13440-2</cfPersNameId>
<cfClassId>55f90543-d631-42eb-8d47-d8d9266cbb26</cfClassId>
<cfClassSchemeId>7375609d-cfa6-45ce-a803-75de69abe21f</cfClassSchemeId>
<cfStartDate>2020T24:00:00</cfStartDate>
<cfFamilyNames>Таран</cfFamilyNames>
<cfFirstNames>Наталья</cfFirstNames>
</cfPersName_Pers>
</cfPers>
<cfPers>
<cfPersId>ibn-Pers-11176</cfPersId>
<cfPersName_Pers>
<cfPersNameId>ibn-PersName-11176-2</cfPersNameId>
<cfClassId>55f90543-d631-42eb-8d47-d8d9266cbb26</cfClassId>
<cfClassSchemeId>7375609d-cfa6-45ce-a803-75de69abe21f</cfClassSchemeId>
<cfStartDate>2020T24:00:00</cfStartDate>
<cfFamilyNames>Hotineanu</cfFamilyNames>
<cfFirstNames>Adrian</cfFirstNames>
</cfPersName_Pers>
</cfPers>
<cfPers>
<cfPersId>ibn-Pers-42616</cfPersId>
<cfPersName_Pers>
<cfPersNameId>ibn-PersName-42616-2</cfPersNameId>
<cfClassId>55f90543-d631-42eb-8d47-d8d9266cbb26</cfClassId>
<cfClassSchemeId>7375609d-cfa6-45ce-a803-75de69abe21f</cfClassSchemeId>
<cfStartDate>2020T24:00:00</cfStartDate>
<cfFamilyNames>Burgoci</cfFamilyNames>
<cfFirstNames>Serghei</cfFirstNames>
</cfPersName_Pers>
</cfPers>
<cfPers>
<cfPersId>ibn-Pers-13436</cfPersId>
<cfPersName_Pers>
<cfPersNameId>ibn-PersName-13436-2</cfPersNameId>
<cfClassId>55f90543-d631-42eb-8d47-d8d9266cbb26</cfClassId>
<cfClassSchemeId>7375609d-cfa6-45ce-a803-75de69abe21f</cfClassSchemeId>
<cfStartDate>2020T24:00:00</cfStartDate>
<cfFamilyNames>Лупашко</cfFamilyNames>
<cfFirstNames>Юлианна</cfFirstNames>
</cfPersName_Pers>
</cfPers>
<cfPers>
<cfPersId>ibn-Pers-11473</cfPersId>
<cfPersName_Pers>
<cfPersNameId>ibn-PersName-11473-2</cfPersNameId>
<cfClassId>55f90543-d631-42eb-8d47-d8d9266cbb26</cfClassId>
<cfClassSchemeId>7375609d-cfa6-45ce-a803-75de69abe21f</cfClassSchemeId>
<cfStartDate>2020T24:00:00</cfStartDate>
<cfFamilyNames>Peltec</cfFamilyNames>
<cfFirstNames>Angela</cfFirstNames>
</cfPersName_Pers>
</cfPers>
</CERIF>